Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 9/20 | 0.48 |
| ▸ | CTSS | P25774 | 6/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863895 | 1.00 | CTSK (0.48) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL863894 | 1.00 | CTSK (0.48) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL18261684 | 0.94 | CTSK (0.44) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2306568 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10606035 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2398972 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6409351 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21685690 | 0.92 | FOLH1 (0.42) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21685691 | 0.92 | FOLH1 (0.42) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL9196011 | 0.90 | CTSK (0.50) | CTSKCTSSCTSLCTSBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528803-A | Deoxypyridinol artificial hapten as well as preparation method and application thereof | 杭州博岳生物技术有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118063718-A | Nanometer medicine for inducing mitochondrial exocytosis and preparation method and application thereof | 四川大学华西医院 | 2024-05-24 | — | — | CN | claimed |
| US-20250352662-A1 | ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS | MERSANA THERAPEUTICS INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-12440576-B2 | Antibody drug conjugates comprising sting agonists | MERSANA THERAPEUTICS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-4622966-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| EP-4598928-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | Radionetics Oncology, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-12344597-B2 | Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-07-01 | — | — | US | disclosed |
| CN-119528803-A | Deoxypyridinol artificial hapten as well as preparation method and application thereof | 杭州博岳生物技术有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12156870-B2 | Antibody drug conjugates comprising sting agonists | MERSANA THERAPEUTICS, INC. (US) | 2024-12-03 | — | — | US | disclosed |
| CN-113412271-B | Having cysteine residues Hamiltelin derivatives of (C) | 住友制药株式会社 | 2024-10-22 | — | — | CN | disclosed |
| CN-118725014-A | Mitochondrial targeting peptides | 隐形生物治疗公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20200190101-A1 | Composition Containing Novel Glutamic Acid Derivative And Block Copolymer, And Use Thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2020-06-18 | — | — | US | disclosed |
| WO-2019118878-A1 | MITOCHONDRIA-TARGETING PEPTIDES | STEALTH BIOTHERAPEUTICS CORP. (MC) | 2019-06-20 | — | — | WO | disclosed |
| CN-109517039-A | Peptide compound, application thereof and composition containing peptide compound | 凯惠科技发展(上海)有限公司 | 2019-03-26 | — | — | CN | disclosed |
| WO-2019031614-A1 | ANTIBODY-DRUG CONJUGATES INCLUDING HEMIASTERLIN DERIVATIVE | 大日本住友製薬株式会社 | 2019-02-14 | — | — | WO | disclosed |
| EP-3378495-A1 | COMPOSITION COMPRISING NOVEL GLUTAMIC ACID DERIVATIVE AND BLOCK COPOLYMER, AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-9636409-B2 | Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-05-02 | — | — | US | disclosed |
| US-20160151509-A1 | ENZYME AND RECEPTOR MODULATION | GLAXOSMITHKLINE IP DEV LTD (GB) | 2016-06-02 | — | — | US | disclosed |
| US-20140088159-A1 | ENZYME AND RECEPTOR MODULATION | CHROMA THERAPEUTICS LTD. (GB) | 2014-03-27 | — | — | US | disclosed |
| US-20100317865-A1 | ENZYME AND RECEPTOR MODULATION | c/o Chroma Therapeutics Ltd. (GB) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12156870-B2 | Antibody drug conjugates comprising sting agonists | STING1, CGAS, IFNAR1 | CTSK 1976/4885CTSS 2082/4885CYP1A2 3483/4885 |
| US-20140088159-A1 | ENZYME AND RECEPTOR MODULATION | CES1, GLRB, GLRA1 | CTSK 736/4885CTSS 503/4885CYP1A2 841/4885 |
| US-12440576-B2 | Antibody drug conjugates comprising sting agonists | STING1, CGAS, IFNAR1 | CTSK 1976/4885CTSS 2082/4885CYP1A2 3483/4885 |
| US-12344597-B2 | Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis | LPAR1, LPAR3, LPAR2 | CTSK 2480/4885CTSS 2460/4885CYP1A2 899/4885 |
| US-20200190101-A1 | Composition Containing Novel Glutamic Acid Derivative And Block Copolymer, And Use Thereof | GGCT, GGT1, TGM2 | CTSK 3869/4885CTSS 3506/4885CYP1A2 3215/4885 |
| US-20160151509-A1 | ENZYME AND RECEPTOR MODULATION | CES1, GLRB, GLRA1 | CTSK 736/4885CTSS 503/4885CYP1A2 841/4885 |
| US-20250352662-A1 | ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS | STING1, CGAS, IFNAR1 | CTSK 1976/4885CTSS 2082/4885CYP1A2 3483/4885 |
| US-20100317865-A1 | ENZYME AND RECEPTOR MODULATION | CES1, GLRB, GLRA1 | CTSK 736/4885CTSS 503/4885CYP1A2 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.